Werba Rubin Papier Wealth Management Gilead Sciences, Inc. Transaction History
Werba Rubin Papier Wealth Management
- $619 Billion
- Q3 2025
A detailed history of Werba Rubin Papier Wealth Management transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Werba Rubin Papier Wealth Management holds 7,942 shares of GILD stock, worth $943,827. This represents 0.14% of its overall portfolio holdings.
Number of Shares
7,942
Previous 7,956
0.18%
Holding current value
$943,827
Previous $882 Million
0.07%
% of portfolio
0.14%
Previous 0.17%
Shares
9 transactions
Others Institutions Holding GILD
# of Institutions
2,362Shares Held
1.03BCall Options Held
12.1MPut Options Held
9.11M-
Black Rock Inc. New York, NY121MShares$14.3 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA119MShares$14.1 Billion0.21% of portfolio
-
State Street Corp Boston, MA59.2MShares$7.03 Billion0.25% of portfolio
-
Capital World Investors Los Angeles, CA46.3MShares$5.5 Billion0.78% of portfolio
-
Wellington Management Group LLP Boston, MA37.5MShares$4.46 Billion0.79% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $149B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...